086450.KQ
DongKook Pharmaceutical Co., Ltd.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 21,800.00
−0.23%Margins
Gross margin
54.8%
EBITDA margin
13.9%
EBIT margin
10.5%
Net margin
7.8%
FCF margin
3.7%
11.0%
Return on equity
6.8%
Return on assets
13.4%
Return on invested capital
0.89x
Asset turnover
KRW 93.0B
Cash from operations
KRW 2.7K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026